ANTIBODY TITRATION is critical to the success of any flow cytometry experiment. This is even more so in microflow cytometric analysis of extracellular vesicles (EVs), where removing excess antibodies ...
Recent advances in analytical techniques have increased the efficiency of therapeutic antibody discovery and facilitated rapid growth of the mono-clonal antibody (mAb) market over the past 25 years.
In recent years, antibodies have become an incredibly popular therapeutic target – with monoclonal antibodies (mAbs) becoming an ever more widely used therapy for a number of diseases, including ...
The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this has been the advancement of technologies that improve the time and efficiency of ...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with ...
Monoclonal antibody (mAb) therapeutics comprise one of the most rapidly growing drug classes, with over 100 mAbs approved for use by the US FDA. The success of mAbs as a class of therapeutics is ...
Flow cytometry is a powerful method for the quantification of microorganisms, unparalleled by other technologies. We will (1) give an overview of the benefits and use cases of flow cytometry for ...
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a ...
Flow cytometry is a way to look closely at the features of cells or particles. A sample of blood or tissue goes into a machine called a cytometer. In less than a minute, a computer can analyze ...
To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results